Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Fluoxetine plus dexfenfluramine effective in obese patients

Jan. 3, 1997

Lilly claims IGF-1 superagonists

Jan. 3, 1997

New vitamin D derivatives from Duphar

Jan. 3, 1997

Japanese researchers focus on pyripyropenes

Jan. 3, 1997

Norian begins trial of Norian SRS in hip fractures

Jan. 2, 1997

Osiris provides funds for clinical trial of hMSCs

Jan. 2, 1997

Novo Nordisk clear to market hGH product in U.S.

Jan. 2, 1997

Crinone efficacy equal to that of higher doses of oral progesterone in IVF procedures

Jan. 2, 1997

Hyperprolactinemia Rx approved by FDA

Dec. 31, 1996

Nutropin cleared for marketing

Dec. 31, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.